| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 144 |
| 16 Nov 2026 | Form 4 |
| 16 Nov 2026 | Form 4 |
| 12 Nov 2026 |
Form 4: Hibbs Kathy L, Director
Sold 6,250 shares ($48.5K) |
| 12 Nov 2026 |
Form 4: Camblong Jurgi, Director
Sold 8,500 shares ($65.9K) |
| 12 Nov 2026 |
Form 4: Van Well Daan, Chief Legal Officer
Sold 1,411 shares ($10.5K) |
| 12 Nov 2026 | SCHEDULE 13D/A |
| 09 Nov 2026 | 144 |
| 09 Nov 2026 |
Form 4: Cardoza George, Chief Financial Officer
Bought 20,000 shares ($141K) |
| 09 Nov 2026 |
Form 4: Muken Ross, Director
Bought 20,000 shares ($137K) |
| 03 Nov 2026 | 6-K |
| 14 Oct 2026 |
Form 4: Menu Philippe, Chief Medical Officer
Sold 5,000 shares ($36.3K) |
| 14 Oct 2026 |
Form 4: Xu Zhenyu, Chief Scientific Officer
Sold 4,000 shares ($28.7K) |
| 14 Oct 2026 |
Form 4: Camblong Jurgi, Director
Sold 8,500 shares ($61.7K) |
| 07 Oct 2026 |
Form 4: Van Well Daan, Chief Legal Officer
Sold 6,168 shares ($50.1K) |
| 07 Oct 2026 |
Form 4: Valente Manuela, Chief People Officer
Sold 4,240 shares ($34.5K) |
| 07 Oct 2026 |
Form 4: Verma Abhimanyu, Chief Technology Officer
Sold 5,284 shares ($42.9K) |
| 07 Oct 2026 |
Form 4: Puylaert Kevin, Chief Sales Officer
Sold 216 shares ($1.74K) |
| 07 Oct 2026 |
Form 4: Cardoza George, Chief Financial Officer
Sold 1,592 shares ($12.9K) |
| 07 Oct 2026 |
Form 4: Menu Philippe, Chief Medical Officer
Sold 7,394 shares ($60.1K) |
Loading...